CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published ahead of print on June 8, 2006
Clinical Journal of the American Society of Nephrology
© 2006 American Society of Nephrology
doi: 10.2215/CJN.01581105
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
CJN.01581105v1
1/4/710    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dicks, E.
Right arrow Articles by Parfrey, P. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dicks, E.
Right arrow Articles by Parfrey, P. S.

Received November 4, 2005
Accepted on April 27, 2006

ORIGINAL ARTICLES

Incident Renal Events and Risk Factors in Autosomal Dominant Polycystic Kidney Disease: A Population- and Family-Based Cohort Followed for 22 Years

Elizabeth Dicks *, Pietro Ravani *{dagger}, Deanna Langman {ddagger}, William S. Davidson {ddagger}, York Pei {sect}, and Patrick S. Parfrey *1

*Clinical Epidemiology Unit and Division of Nephrology, Memorial University of Newfoundland, St. John’s, Newfoundland, {ddagger}Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, and {sect}Renal Unit, University of Toronto, Toronto, Ontario, Canada; and {dagger}Nephrology, Azienda Instituti Ospitalieri di Cremona, Cremona, Italy


1 To whom correspondence should be addressed. E-mail: pparfrey{at}mun.ca.


   Abstract

For determination of the incidence of renal events in autosomal dominant polycystic kidney disease (ADPKD) all patients who had ADPKD and attended nephrology/urology clinics in Newfoundland in 1981 were identified, and members of 18 families who were at 50% risk for inheriting ADPKD were followed prospectively for 22 yr, including research clinics at 6-yr intervals. Time to hypertension treatment, stage 3 chronic kidney disease (CKD), ESRD, and death was measured, and the impact of genotype, gender, gender of parent who transmitted PKD, family, family history of essential hypertension, parity, and oral contraceptive pill was assessed. Nine (50%) families had PKD1, four (22%) had PKD2, and one had both PKD1 and PKD2. The number of family members with PKD1 was 136 and with PKD2 was 60. In PKD1 median age to hypertension treatment was 46 yr, to CKD stage 3 was 50 yr, to ESRD was 53 yr, and to death was 67 yr. In PKD2, median age to hypertension treatment was 51 yr, to CKD stage 3 was 66 yr, to death was 71 yr, and ESRD was infrequent. Although the incidence of CKD was later and ESRD occurred infrequently in PKD2 compared with PKD1, early onset of hypertension occurred and life expectancy was compromised. Genotype, family, and proteinuria were identified as risk factors for incident renal events. Gender, gender of parent who transmitted PKD, family history of essential hypertension, multiparity, and use of the oral contraceptive pill were not identified as risk factors for renal events in ADPKD.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the American Society of Nephrology.